Abstract
2',5' oligoadenylate synthetase (2-5AS), an enzyme induced by interferon, is an accurate indicator of the antiviral effect of interferon. We measured it during pegylated interferon based therapies in patients with chronic hepatitis C virus (HCV) in order to determine the dynamics of antiviral status in vivo and the relationship between the response to exogenous interferon and the outcome of therapy. A total of 160 patients with chronic HCV were treated with pegylated interferon alfa 2a or 2b or non-pegylated interferon, with or without ribavirin. Serum 2-5AS activity was measured by radioimmunoassay assay kits every 2 weeks. In 60 patients treated with pegylated interferon alfa 2a or 2b, 2-5AS levels increased to 7-40 times (average 235 pmol/dL) above the pretreatment levels (30 pmol/dL), which were significantly higher than the levels during non-pegylated interferon therapy. Ribavirin did not enhance 2-5AS levels. 2-5AS levels between sustained virological response (SVR) and non-SVR, including null responders to pegylated interferon plus ribavirin therapy were not significantly different. 2-5AS levels were significantly higher in patients treated with pegylated interferon than in those treated with non-pegylated interferon, su...Continue Reading
References
Jan 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·I M Kerr, R E Brown
Mar 1, 1988·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M ShindoY Sokawa
Sep 1, 1986·Journal of Clinical Microbiology·H SuginoY Sokawa
Oct 1, 1985·Journal of Biochemistry·H SawaiS Watanabe
Jan 1, 1981·Journal of Interferon Research·A SchattnerM Revel
Aug 19, 1999·The New England Journal of Medicine·M J AlterH S Margolis
Oct 5, 2001·Lancet·M P MannsJ K Albrecht
Sep 27, 2002·The New England Journal of Medicine·Michael W FriedJian Yu
Aug 27, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Gary L DavisJanice Albrecht
Mar 5, 2004·Annals of Internal Medicine·Stephanos J HadziyannisUNKNOWN PEGASYS International Study Group
Nov 9, 2004·Advances in Virus Research·Ralf BartenschlagerThomas Pietschmann
Jul 2, 2005·Journal of Hepatology·Peter FerenciK Rajender Reddy
Mar 28, 2006·Journal of Medical Virology·Adrian M Di BisceglieJanice Strinko
Apr 22, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Donald M JensenBernard Willems
Citations
Apr 12, 2014·Clinical Pharmacokinetics·Clara T M M de KanterDavid M Burger
Dec 1, 2012·FEBS Letters·Young-Chan KwonByung-Yoon Ahn
Nov 26, 2015·Immunology·Asif A DarShubhada V Chiplunkar
Dec 6, 2011·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Eiji KajiwaraNaoki Yamashita
Apr 12, 2020·Viruses·Xinzhong LiaoLimin Chen